CCL2 and chronic kidney disease: Furthermore, higher urinary MCP-1 levels have been associated with chronic tubulointerstitial damage and CKD progression in various settings such as IgA nephropathy, diabetes mellitus, and obstructive uropathy (17, 19, 28, 31).